These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30443180)

  • 1. Pin1 Is Involved in HDAC6-mediated Cancer Cell Motility.
    Chuang HH; Huang MS; Wang PH; Liu YP; Hsiao M; Yang CJ
    Int J Med Sci; 2018; 15(13):1573-1581. PubMed ID: 30443180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pin1 coordinates HDAC6 upregulation with cell migration in lung cancer cells.
    Chuang HH; Hsu JF; Chang HL; Wang PH; Wei PJ; Wu DW; Huang MS; Hsiao M; Yang CJ
    Int J Med Sci; 2020; 17(17):2635-2643. PubMed ID: 33162791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G Protein-coupled Receptor Kinase 2 (GRK2) Promotes Breast Tumorigenesis Through a HDAC6-Pin1 Axis.
    Nogués L; Reglero C; Rivas V; Salcedo A; Lafarga V; Neves M; Ramos P; Mendiola M; Berjón A; Stamatakis K; Zhou XZ; Lu KP; Hardisson D; Mayor F; Penela P
    EBioMedicine; 2016 Nov; 13():132-145. PubMed ID: 27720394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells.
    Thomas AL; Lind H; Hong A; Dokic D; Oppat K; Rosenthal E; Guo A; Thomas A; Hamden R; Jeruss JS
    Cell Cycle; 2017 Aug; 16(15):1453-1464. PubMed ID: 28678584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of peptidyl-prolyl isomerase Pin1 in disease pathogenesis.
    Li J; Mo C; Guo Y; Zhang B; Feng X; Si Q; Wu X; Zhao Z; Gong L; He D; Shao J
    Theranostics; 2021; 11(7):3348-3358. PubMed ID: 33537091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidyl-prolyl cis-trans isomerase NIMA interacting 1 regulates skeletal muscle fusion through structural modification of Smad3 in the linker region.
    Islam R; Yoon H; Shin HR; Bae HS; Kim BS; Yoon WJ; Woo KM; Baek JH; Lee YS; Ryoo HM
    J Cell Physiol; 2018 Dec; 233(12):9390-9403. PubMed ID: 30132832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-150-5p inhibits the proliferation and invasion of human larynx epidermiod cancer cells though regulating peptidyl-prolyl cis/trans isomerase.
    Chen H; Cai X; Du B; Cai J; Luo Z
    Braz J Otorhinolaryngol; 2023; 89(3):383-392. PubMed ID: 37105032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual Roles of Pin1 in Cancer Development and Progression.
    Han HJ; Choi BY; Surh YJ
    Curr Pharm Des; 2017 Nov; 23(29):4422-4425. PubMed ID: 28671058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the functional behavior of the differentially phosphorylated prolyl isomerase, Pin1.
    Kay DF; Ozleyen A; Heras CML; Doveston RG; Leney AC
    Protein Sci; 2024 Sep; 33(9):e5138. PubMed ID: 39150071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases.
    Legname G; Virgilio T; Bistaffa E; De Luca CMG; Catania M; Zago P; Isopi E; Campagnani I; Tagliavini F; Giaccone G; Moda F
    Prion; 2018 Mar; 12(2):127-137. PubMed ID: 29676205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic crosstalk between PIN1 and the tumour microenvironment.
    Caligiuri I; Vincenzo C; Asano T; Kumar V; Rizzolio F
    Semin Cancer Biol; 2023 Jun; 91():143-157. PubMed ID: 36871635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen-independent stabilization of HIF-2α in breast cancer through direct interaction with peptidyl-prolyl cis-trans isomerase NIMA-interacting 1.
    Guillen-Quispe YN; Kim SJ; Saeidi S; Zhou T; Zheng J; Kim SH; Fang X; Chelakkot C; Rios-Castillo ME; Shin YK; Surh YJ
    Free Radic Biol Med; 2023 Oct; 207():296-307. PubMed ID: 37473874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer.
    Stifani S
    Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30314361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer.
    Saeidi S; Kim SJ; Guillen-Quispe YN; Jagadeesh ASV; Han HJ; Kim SH; Zhong X; Piao JY; Kim SJ; Jeong J; Shin YJ; Cha YJ; Lee HB; Han W; Min SH; Tian W; Kitamura H; Surh YJ
    FASEB J; 2022 Jan; 36(1):e22068. PubMed ID: 34918396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Pin1 in the development and treatment of cancer.
    Min SH; Zhou XZ; Lu KP
    Arch Pharm Res; 2016 Dec; 39(12):1609-1620. PubMed ID: 27572155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 as a molecular target in breast cancer: a therapeutic perspective of gynecological cancer.
    Kim G; Bhattarai PY; Choi HS
    Arch Pharm Res; 2019 Feb; 42(2):128-139. PubMed ID: 30684192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pin1 promotes transforming growth factor-beta-induced migration and invasion.
    Matsuura I; Chiang KN; Lai CY; He D; Wang G; Ramkumar R; Uchida T; Ryo A; Lu K; Liu F
    J Biol Chem; 2010 Jan; 285(3):1754-64. PubMed ID: 19920136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peptidyl-prolyl cis/trans isomerase Pin1 interacts with three early regulatory proteins of human cytomegalovirus.
    Schütz M; Thomas M; Wangen C; Wagner S; Rauschert L; Errerd T; Kießling M; Sticht H; Milbradt J; Marschall M
    Virus Res; 2020 Aug; 285():198023. PubMed ID: 32428517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of eukaryotic protein kinases by Pin1, a peptidyl-prolyl isomerase.
    Chen XR; Igumenova TI
    Adv Biol Regul; 2023 Jan; 87():100938. PubMed ID: 36496344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the Minichromosome Maintenance Protein 3 (MCM3) Chromatin Binding by the Prolyl Isomerase Pin1.
    Schumann M; Malešević M; Hinze E; Mathea S; Meleshin M; Schutkowski M; Haehnel W; Schiene-Fischer C
    J Mol Biol; 2018 Dec; 430(24):5169-5181. PubMed ID: 30316783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.